Key Metrics 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Mesco Pharmaceuticals Ltd (MESCOPHARM)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 500274 NSE: MESCOPHARM Pharmaceuticals & Drugs | Small Cap | Mesco Pharma Share Price
₹4.54 0.00 (0.00%)
As on 10-Jan'22 18:01
Mesco Pharmaceuticals Ltd (MESCOPHARM)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 500274 NSE: MESCOPHARM Pharmaceuticals & Drugs | Small Cap | Mesco Pharma Share Price
₹4.54 0.00 (0.00%)
As on 10-Jan'22 18:01
Key Metrics
Valuation Multiples
Market Cap
₹9 Cr.
Current Price
₹4.5
52-Week Low / High
₹5 / 5
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
53.6
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
-
-
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
39.30%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹20.3 Cr.
Face Value
₹10
All Time Low / High
₹0.60 / 58.00
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation ⓘ
| Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | -8.4% | -0% | 0.1% | -194.3% | 5.1% | -108.6% | -36.3% | -176.1% | -45.8% | -2.1% | - |
| Value Creation Index ⓘ | -1.6 | -1.0 | -1.0 | NA | -0.6 | NA | NA | NA | NA | -1.2 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales YoY Gr. | - | NA | NA | NA | NA | NA | NA | NA | NA | NA | - |
| Adj EPS ⓘ | -2.1 | -0 | -0 | -22.7 | 0 | -0.1 | -0 | -0.2 | -0.1 | -0 | 0 |
| YoY Gr. | - | NA | NA | NA | NA | -1400% | NA | NA | NA | NA | - |
| BVPS (₹) ⓘ | 18.2 | 18.2 | 18.2 | -5.2 | -5.2 | -5.3 | -5.3 | -5.5 | -5.6 | -5.6 | -5.1 |
| Adj Net Profit ⓘ | -4.2 | -0 | -0 | -46.1 | 0 | -0.3 | -0.1 | -0.4 | -0.1 | -0 | 0 |
| Cash Flow from Ops. ⓘ | -2.3 | -0.2 | 0.7 | -0.2 | 0 | -0.3 | -0.1 | -0.4 | -0.1 | -0 | - |
| Debt/CF from Ops. ⓘ | -4.7 | -48.9 | 16.7 | -51.2 | 311.2 | -40.3 | -122.1 | -28.3 | -142.4 | -5587.8 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | NA | NA | NA | ||||
| Adj EPS ⓘ | NA | -100% | NA | NA | ||||
| BVPSⓘ | -187.7% | NA | NA | NA | ||||
| Share Price | - | -4.4% | - | - | ||||
Key Financial Parameters ⓘ
| Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | -11.2 | -0 | -0 | -358 | -0.2 | 2.5 | 0.8 | 3.8 | 0.9 | 0 | -0 |
| Op. Profit Mgn % ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | NAN |
| Net Profit Mgn % ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | NAN |
| Debt to Equity ⓘ | 0.3 | 0.3 | 0.3 | -1.1 | -1 | -1 | -1 | -1 | -1 | -1 | - |
| Working Cap Days ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Conv. Cycle ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Valuation of Mesco Pharma - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
No data found!
No data found!
No data found!
No data found!
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Mesco Pharmaceuticals Ltd FAQs
The current trading price of Mesco Pharma on 10-Jan-2022 18:01 is ₹4.54.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 09-Jan-2022 the market cap of Mesco Pharma stood at ₹9.23 Cr
The latest P/E ratio of Mesco Pharma as of 09-Jan-2022 is 0.00.
The latest P/B ratio of Mesco Pharma as of 09-Jan-2022 is -0.88.
The 52-week high of Mesco Pharma is ₹4.54 and the 52-week low is ₹4.54.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Mesco Pharma is ₹0.00 ( Cr.) .
Data is not available for this company.
The key valuation ratios of Mesco Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.
No data found
About Mesco Pharmaceuticals Ltd
Mesco Pharmaceuticals Ltd is Public Limited Company listed with Bombay Stock Exchange Limited, Calcutta Stock Exchange and Ahmedabad Stock Exchange, established in 1986.
The Company was originally promoted and incorporated as public limited company under the provisions of Companies Act, 1956 under the jurisdiction of Registrar of Companies, Sri Nagar. The Registered office of the Company is shifted from Jammu and Kashmir to Uttar Pradesh on November 10, 1993. At Present the Registered Office of the Company is situated at Upper Kesalton, Tallital, Nainital-263 001, Uttarakhand.
The Company commenced commercial operations in June 1991 by venturing into Seed Marketing of Bulk Drugs and Formalities. However, the operations of the company came to a standstill for more than 15 years due to taking over of the factory building and other assets of the company in Dehradun by UP State Financial Corporation. Though, the Board of the Company is in the process of evaluating alternative business opportunities which the company may choose to enter into the future.
Business area of the company
The company manufactures and distributes a wide range of pharmaceutical products. The Company manufactures bulk drugs and formulations which are sold domestically in India and abroad. However, the business activity of the company was closed since many years.
You have 47 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
